Age-related Macular Degeneration Market
Age-related Macular Degeneration Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Age-related Macular Degeneration Market Size and Growth
The Age-related Macular Degeneration (AMD) market is expanding due to increasing prevalence and aging populations. Valued at approximately $8 billion in 2023, the market is projected to grow significantly, driven by advancements in treatment options and increased awareness. Competitive landscapes highlight emerging therapies and strategic partnerships, shaping future growth trajectories.
Companies Covered
(Covid 19 Impact Covered)
◍ Bayer HealthCare
◍ F. Hoffmann-La Roche
◍ Novartis
◍ Regeneron Pharmaceuticals
◍ Alcon
◍ Allergan
◍ Avalanche
◍ Bausch+Lomb
◍ Gilead Sciences
◍ Iconic Therapeutics
◍ Neurotech Pharmaceuticals
◍ Ohr Pharmaceutical
The Age-related Macular Degeneration (AMD) market is competitive, with key players like Bayer, Roche, and Novartis developing innovative treatments and therapies. Companies leverage R&D, advanced drug formulations, and marketing strategies to drive growth. Notable revenue figures include Regeneron's Eylea, generating billions in sales annually, bolstering overall market expansion.
Request Sample Report
Market Segmentation
By Application
Drugstore
Others
Request Sample Report
By Product
Market Growth
Request Sample Report
$ X Billion USD
